Interestingly, a three-biomarker panel consisting of CEA, C9, and FN1 demonstrated an ideal performance in discriminating between CRC patients and healthy controls with AUC value of 1.00 and provided 100% predictive accuracy. Here, C9 is linked to colorectal carcinoma.